Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
CMC Strategy Forum Latin America 2017
Share |




We expect you have seen news reports of the severe earthquake in Mexico, and some of you are asking if or how this will affect the CMC Strategy Forum in October.

You can be confident that we are monitoring events in Mexico closely. We are in touch regularly with the hotel.  The hotel is open and operating normally.  Based on these discussions and information from our contacts in Mexico City, it is our hope and expectation that areas we will be visiting will be accessible.

That said, please know that we place the safety of our attendees and our staff as our primary concern, and that we will make all decisions with that as our primary motivator. Should some changes be necessary, we have contingency plans in place so we can adjust events.

For the next two weeks, we will continue to monitor the progress of the recovery, and you can rest assured that we will keep you and all registrants informed as things progress. We hope you, too, will give things a few days, before making decisions about your travel. In the meantime, we continue to gear up for an excellent Forum.

We look forward to seeing you soon!


On behalf of the CASSS Board of Directors and the CMC Strategy Forum Global Steering Committee, I would like to extend to you a warm welcome to the fourth meeting of the CMC Strategy Forum Latin America 2017 that will be held 9-10 October 2017 in Mexico City, Mexico. We are very pleased to have the strong support from COFEPRIS-Federal Commission for the Protection against Sanitary Risk regulatory agency in Mexico, as well as AMIIF, CANIFARMA and several other Latin America regulatory agencies (Brasil, Argentina, Chile, Ecuador and Peru), as well as the continued support by CASSS and the United States Food and Drug Administration. The Forum will follow the established model of the CMC Forum series with focus on topics and regulatory updates relevant for Latin America and will feature an opening regulatory session that will include presentations from COFEPRIS, ANVISA, AEMPS, DIGEMID, as well as the FDA and EMA. In addition, FIFARMA is planning a half-day session to discuss “Reliance and Recognition – Good Regulatory Practices to Solve Capacity Issues and Accelerate Access” and “PANDRH – Procedure for Prioritizing Areas of Work and FIFARMA’s Project Proposals”. The technical sessions will include discussion on: “ICH CTD Structure for Module 3 for Biotech” and “Stability for Biotech Products”.

With this exciting program, I would like to extend to you an invitation to attend and participate actively in making this Forum a great success.

Wassim Nashabeh
On behalf of the CMC Strategy Forum Global Steering Committee




 Want more information? Check out the "More in this Section" dropdown box at the top of the page!

Or contact CASSS at 510-428-0740 or





Membership Software Powered by YourMembership  ::  Legal